Lipocine Inc (LPCN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2023 | 12-2022 | 09-2022 | 06-2022 | 03-2022 | |
| Sales | 55 | 0 | 0 | 500 | 0 |
| Gross Profit | 55 | N/A | N/A | 500 | N/A |
| Operating Expenses | 4,394 | 2,561 | 2,899 | 4,028 | 3,132 |
| Operating Income | -4,339 | -2,561 | -2,899 | -3,528 | -3,132 |
| Interest Expense | 0 | 0 | 0 | 8 | 20 |
| Other Income | 469 | 331 | 490 | 903 | -337 |
| Pre-tax Income | -3,870 | -2,229 | -2,409 | -2,632 | -3,488 |
| Income Tax | 0 | -1 | N/A | N/A | 0 |
| Net Income Continuous | -3,870 | -2,229 | -2,409 | -2,632 | -3,488 |
| Net Income | $-3,870 | $-2,230 | $-2,409 | $-2,632 | $-3,488 |
| EPS Basic Total Ops | -0.74 | -0.42 | -0.46 | -0.50 | -0.68 |
| EPS Basic Continuous Ops | -0.74 | -0.42 | -0.46 | -0.50 | -0.67 |
| EPS Diluted Total Ops | -0.76 | -0.34 | -0.52 | -0.61 | -0.68 |
| EPS Diluted Continuous Ops | -0.74 | -0.42 | -0.46 | -0.50 | -0.67 |
| EBITDA(a) | $-4,588 | $-2,717 | $-2,947 | $-3,489 | $-3,079 |